GGrantIndex
Sort

30,917 grants matching tumor microenvironment

Metabolic Barriers to T Cell Activation in Clear Cell Renal Cell Carcinoma

$439,237
Jeffrey C Rathmell · Vanderbilt University Medical Center · R01 · FY2021 · CA

TGF-beta Suppression and Promotion of Mammary Carcinomas

$439,217
Harold L Moses · Vanderbilt University · R01 · FY2014 · CA

Bi-directional interactions with tumor microenvironment enhance BRCA1-IRIS overexpressing TNBC tumor cells aggressiveness

$439,200
Wael M. Elshamy · San Diego Biomedical Research Institute · R01 · FY2018 · CA

Boosting Antitumor Immunity by Blocking Both Tumor and Adipose DDR1

$439,100
Rong Li · George Washington University · R01 · FY2024 · CA

Tackling Treg mediated resistance to radiation and anti-PDL1 in HNSCCs

$439,092
Sana D Karam · University Of Colorado Denver · R01 · FY2023 · DE

Tackling Treg mediated resistance to radiation and anti-PDL1 in HNSCCs

$439,092
Sana D Karam · University Of Colorado Denver · R01 · FY2019 · DE

Tackling Treg mediated resistance to radiation and anti-PDL1 in HNSCCs

$439,092
Sana D Karam · University Of Colorado Denver · R01 · FY2020 · DE

Tackling Treg mediated resistance to radiation and anti-PDL1 in HNSCCs

$439,092
Sana D Karam · University Of Colorado Denver · R01 · FY2021 · DE

Estrogen and Its Receptors in Angiogenesis

$439,066
Charlotte Kuperwasser · Beth Israel Deaconess Medical Center · P01 · FY2011 · CA

Preclinical Testing of Targeted Therapies for Neurofibromas

$438,900
David W. Clapp · Indiana University Indianapolis · U01 · FY2011 · NS

Preclinical Testing of Targeted Therapies for Neurofibromas

$438,900
David W. Clapp · Indiana University Indianapolis · U01 · FY2011 · NS

Collagen remodeling and tumor progression

$438,845
Valerie Marie Weaver · University Of California, San Francisco · R01 · FY2010 · CA

INTERCELLULAR COMMUNICATION AND THE RADIATION-INDUCED BYSTANDER EFFECT

$438,842
Edouard I Azzam · Columbia University Health Sciences · P01 · FY2011 · CA

Therapy with fecal microbiota transplantation and immune checkpoint blockade for solid tumors

$438,800
Hassane M Zarour · University Of Pittsburgh At Pittsburgh · U01 · FY2024 · CA

Viscotaxis: Novel cell migration mechanisms regulated by microenvironmental viscosity

$438,793
Konstantinos Konstantopoulos · Johns Hopkins University · R01 · FY2024 · CA

Normalization of tumor vasculature by R-Ras

$438,750
Masanobu Komatsu · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2015 · CA

Normalization of tumor vasculature by R-Ras

$438,750
Masanobu Komatsu · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2016 · CA

Normalization of tumor vasculature by R-Ras

$438,750
Masanobu Komatsu · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2014 · CA

Image-guided Trp-IDO/TDO-Kyn-AHR pathway inhibition, combined with immunotherapy

$438,732
Taha Merghoub · Weill Medical Coll Of Cornell Univ · R01 · FY2024 · CA

S100A4 mediated immune suppression in GBM

$438,652
Kyuson Yun · Methodist Hospital Research Institute · R01 · FY2022 · NS

S100A4 mediated immune suppression in GBM

$438,652
Kyuson Yun · Methodist Hospital Research Institute · R01 · FY2023 · NS

Data Analysis Unit

$438,542
Kai Tan · Children'S Hosp Of Philadelphia · U2C · FY2018 · CA

(PQ1) Genomic characterization of mesenchymal stromal cells in Monoclonal Gammopathy of Undermined Significance (MGUS)

$438,499
Irene M. Ghobrial · Dana-Farber Cancer Inst · R01 · FY2016 · CA

(PQ1) Genomic characterization of mesenchymal stromal cells in Monoclonal Gammopathy of Undermined Significance (MGUS)

$438,499
Irene M. Ghobrial · Dana-Farber Cancer Inst · R01 · FY2020 · CA

(PQ1) Genomic characterization of mesenchymal stromal cells in Monoclonal Gammopathy of Undermined Significance (MGUS)

$438,499
Irene M. Ghobrial · Dana-Farber Cancer Inst · R01 · FY2017 · CA